Vituro Health, Stephen Scionti, M.D., bring precision healthcare and latest prostate cancer treatment options to U.S. patients
November 19, 2015
The presence of prostate cancer can be signaled by an elevated prostate-specific antigen (PSA) level, a test result which can be alarming to any patient and confirmed by a prostate biopsy. Vituro Health, a comprehensive prostate care provider that empowers men during all stages of life, has launched operations to offer complete prostate management services, including minimally-invasive high intensity focused ultrasound (HIFU) therapy. Until now, HIFU has only been available to patients internationally.
Press Tags: PSA.